Fyi here the response I received to the link regarding the trial.
"Just to confirm this press release is about the ongoing Phase 3 randomized controlled trial of remestemcel-L in patients with COVID-19 acute respiratory distress syndrome. This is being conducted in up to 30 hospitals, and now includes the Texas Heart Institute. Thank you for your support" Julie
Cell Therapy News/Articles, page-7713
-
- There are more pages in this discussion • 10,309 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.015(1.51%) |
Mkt cap ! $1.124B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 97.5¢ | $770.9K | 782.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 49095 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 35473 | 27 |
View Market Depth
| Last trade - 12.13pm 20/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |